Cell Culture Media Market Opportunities, Revenue, Future Scope and Forecast 2027

Cell Culture Media Market by Type (Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application (Biopharmaceutical (mAbs, Vaccine) - Global Forecast to 2026

The global cell culture media market size is projected to USD 10.3 billion by 2026, at a CAGR of 16.0%. The growth of this market is majorly driven by the rising RD spending in pharmaceutical companies, emerging cell culture technologies for cell-based vaccines, increasing demand for monoclonal antibodies, growth in stem cell research, the launch of new cell culture media by market players, and the growing focus on personalized medicine. On the other hand, expensive cell biology research products and ethical concerns regarding cell biology research are expected to hinder the growth of this market.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97468536

Market Growth Drivers:

  • Rising RD spending in pharmaceutical companies
  • Emerging cell culture technologies for cell-based vaccines
  • Increasing demand for monoclonal antibodies
  • Growth in stem cell research
  • Launch of new cell culture media products by market players
  • Growing focus on personalized medicine

Market Growth Opportunities

  • Advancements in 3D cell culture
  • Increasing incidence of infectious diseases and outbreaks of pandemics
  • Emerging markets

The prominent players operating in the cell culture media market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson and Company (US), Miltenyi Biotec (Germany), HiMedia Laboratories Pvt. Ltd. (India), STEMCELL Technologies Inc. (Canada), Biologos LLC (US), Cell Applications, Inc. (US)

Thermo Fisher Scientific (US) provides cell culture products, including cell culture media, through its Life Sciences Solutions and Specialty Diagnostics segments. The company has a strong geographic footprint and operates in more than 150 countries across North America, Europe, Latin America, and Asia. From 2019 to 2021, Thermo Fisher launched 4 cell culture media products, including the Gibco CTS NK-Xpander Medium, Gibco Human Plasma-like Medium (HPLM), Gibco CTS OpTmizer Pro Serum-free Media (SFM), and Gibco BenchStable Media. With its strong product portfolio, continuous research and development activities, and broad geographic reach, Thermo Fisher Scientific is expected to witness significant growth in the market.

Danaher Corporation (US) conducts its business through three segments, namely, Life Sciences, Diagnostics, and Environmental Applied Solutions. The Life Sciences business segment offers cell culture media products under Cytiva. The company has a strong geographic presence with subsidiaries across North America, Europe, the Asia Pacific, Latin America, and Africa. Danaher also has a significant focus on strategic collaborations and acquisitions to strengthen its competitive position in the cell culture media market. For instance, in March 2020, Danaher completed the acquisition of General Electric’s Life Sciences Division and renamed it Cytiva to enhance its Life Sciences products and services portfolio.

Merck KGaA (Germany) operates through three business segments, namely, Healthcare, Life Science, and Performance Materials. The Life Science segment is further divided into research solutions, process solutions, and applied solutions subsegments. Merck provides cell culture media products through the research solutions and process solutions subsegments. Merck KGaA is one of the leading players in the cell culture media market. Its key strength lies in its strong product portfolio. The company adopts organic growth strategies such as expansions to increase its dominance in this market. In May 2019, the company completed the expansion to its Irvine biopharmaceutical production facility for the production of both powder and liquid cell culture media.

Get 10% Free Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=97468536

Report Objectives

  • To define, describe, and forecast the global cell culture media market based on type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall cell culture media market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions; new product launches; expansions; and agreements, partnerships, and collaborations in the cell culture media market

Recent Developments

  • In October 2021, Thermo Fisher Scientific Inc. (US) launched the Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, which supports the large-scale growth and culture of functional natural killer (NK) cells with or without the use of feeder cells.
  • In July 2021, Sartorius AG acquired cell culture specialist Xell AG thus expanding its capabilities for manufacturing dry powder and liquid media.

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: [email protected]

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-culture-market.asp 

Visit Our Website: https://www.marketsandmarkets.com/

Content Source: https://www.marketsandmarkets.com/PressReleases/cell-culture.asp


Healthcare101

248 Blog posts

Comments